Aclarion, Inc., a commercial-stage healthcare technology company, has released a new video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon at The London Clinic, discussing his experience with the Nociscan technology for evaluating chronic low back pain. The video highlights real-world physician experience with the diagnostic tool, which has been used for nearly 100 scans at the prestigious private hospital.
Mr. Sutcliffe, who serves as Lead Clinician at The London Spine Clinic and has over 30 years of experience treating spinal conditions, noted that Nociscan provides an additional layer of insight that complements traditional imaging. "Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain," said Sutcliffe in the video, which is available at https://www.aclarion.com/nociscan-video.
Nociscan is a non-invasive solution that helps physicians differentiate between painful and non-painful discs in the lumbar spine by leveraging MR spectroscopy and proprietary signal processing to identify chemical biomarkers associated with disc pain. The technology represents a SaaS platform that receives magnetic resonance spectroscopy data from MRI machines through a cloud connection, where proprietary algorithms analyze biomarker data to indicate if a disc may be a source of pain.
Brent Ness, Chief Executive Officer of Aclarion, stated that approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption. "This video offers a compelling perspective on how Nociscan is being used in day-to-day clinical practice," said Ness. "It reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain."
The growing adoption of Nociscan comes as chronic low back pain affects approximately 266 million people worldwide, representing a significant global healthcare challenge. Clinical data has demonstrated that when used alongside other diagnostic tools, Nociscan has contributed to up to a 97% surgical success rate when all Nociscan-positive discs are treated.
For patients and healthcare providers seeking more information about Nociscan locations, Aclarion maintains a site map at https://www.aclarion.com/find-a-center. The continued use of Nociscan at The London Clinic reflects sustained physician engagement and growing integration of the technology into routine clinical practice for evaluating one of medicine's most common and challenging conditions.
